Annual Accounts Receivable
$54.60 M
-$84.02 M-60.61%
31 December 2023
Summary:
Maravai LifeSciences Holdings annual accounts receivable is currently $54.60 million, with the most recent change of -$84.02 million (-60.61%) on 31 December 2023. During the last 3 years, it has risen by +$3.59 million (+7.03%). MRVI annual accounts receivable is now -60.61% below its all-time high of $138.62 million, reached on 31 December 2022.MRVI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$28.87 M
-$9.78 M-25.30%
30 September 2024
Summary:
Maravai LifeSciences Holdings quarterly accounts receivable is currently $28.87 million, with the most recent change of -$9.78 million (-25.30%) on 30 September 2024. Over the past year, it has dropped by -$16.80 million (-36.78%). MRVI quarterly accounts receivable is now -79.17% below its all-time high of $138.62 million, reached on 31 December 2022.MRVI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRVI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.6% | -36.8% |
| 3 y3 years | +7.0% | -56.2% |
| 5 y5 years | +241.5% | - |
MRVI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.6% | +7.0% | -79.2% | at low |
| 5 y | 5 years | -60.6% | +241.5% | -79.2% | +60.1% |
| alltime | all time | -60.6% | +241.5% | -79.2% | +60.1% |
Maravai LifeSciences Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.87 M(-25.3%) |
| June 2024 | - | $38.65 M(+5.4%) |
| Mar 2024 | - | $36.69 M(-32.8%) |
| Dec 2023 | $54.60 M(-60.6%) | $54.60 M(+19.6%) |
| Sept 2023 | - | $45.67 M(-6.8%) |
| June 2023 | - | $48.99 M(-12.9%) |
| Mar 2023 | - | $56.27 M(-59.4%) |
| Dec 2022 | $138.62 M | $138.62 M(+21.5%) |
| Sept 2022 | - | $114.07 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $120.35 M(-0.0%) |
| Mar 2022 | - | $120.36 M(+2.4%) |
| Dec 2021 | $117.51 M(+130.3%) | $117.51 M(+78.2%) |
| Sept 2021 | - | $65.94 M(-21.1%) |
| June 2021 | - | $83.53 M(-31.4%) |
| Mar 2021 | - | $121.82 M(+138.8%) |
| Dec 2020 | $51.02 M(+183.0%) | $51.02 M(-30.4%) |
| Sept 2020 | - | $73.30 M(+306.6%) |
| Dec 2019 | $18.03 M(+12.8%) | $18.03 M |
| Dec 2018 | $15.99 M | - |
FAQ
- What is Maravai LifeSciences Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual accounts receivable year-on-year change?
- What is Maravai LifeSciences Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly accounts receivable year-on-year change?
What is Maravai LifeSciences Holdings annual accounts receivable?
The current annual accounts receivable of MRVI is $54.60 M
What is the all time high annual accounts receivable for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual accounts receivable is $138.62 M
What is Maravai LifeSciences Holdings annual accounts receivable year-on-year change?
Over the past year, MRVI annual accounts receivable has changed by -$84.02 M (-60.61%)
What is Maravai LifeSciences Holdings quarterly accounts receivable?
The current quarterly accounts receivable of MRVI is $28.87 M
What is the all time high quarterly accounts receivable for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly accounts receivable is $138.62 M
What is Maravai LifeSciences Holdings quarterly accounts receivable year-on-year change?
Over the past year, MRVI quarterly accounts receivable has changed by -$16.80 M (-36.78%)